Search Results - "Journal of the European Academy of Dermatology and Venereology"

Cutaneous manifestations in COVID‐19: a first perspective by Recalcati, S.

Get full text

Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II by Wollenberg, A., Barbarot, S., Bieber, T., Christen‐Zaech, S., Deleuran, M., Fink‐Wagner, A., Gieler, U., Girolomoni, G., Lau, S., Muraro, A., Czarnecka‐Operacz, M., Schäfer, T., Schmid‐Grendelmeier, P., Simon, D., Szalai, Z., Szepietowski, J.C., Taïeb, A., Torrelo, A., Werfel, T., Ring, J.

“…This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a…”
Get full text

Vascular skin symptoms in COVID‐19: a French observational study by Bouaziz, J.D., Duong, T.A., Jachiet, M., Velter, C., Lestang, P., Cassius, C., Arsouze, A., Domergue Than Trong, E, Bagot, M., Begon, E., Sulimovic, L., Rybojad, M

Get full text

Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients by Piccolo, V., Neri, I., Filippeschi, C., Oranges, T., Argenziano, G., Battarra, V.C., Berti, S., Manunza, F., Fortina, A.B., Di Lernia, V., Boccaletti, V., De Bernardis, G., Brunetti, B., Mazzatenta, C., Bassi, A.

Get full text

2020 European guideline on the management of syphilis by Janier, M., Unemo, M., Dupin, N., Tiplica, G.S., Potočnik, M., Patel, R.

“…The 2020 edition of the European guideline on the management of syphilis is an update of the 2014 edition. Main modifications and updates include: ‐The ongoing…”
Get full text

Urticarial eruption in COVID‐19 infection by Henry, D., Ackerman, M., Sancelme, E., Finon, A., Esteve, E.

Get full text

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa by Zouboulis, C.C., Desai, N., Emtestam, L., Hunger, R.E., Ioannides, D., Juhász, I., Lapins, J., Matusiak, L., Prens, E.P., Revuz, J., Schneider-Burrus, S., Szepietowski, J.C., van der Zee, H.H., Jemec, G.B.E.

“…Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, recurrent, debilitating skin disease of the hair follicle that usually presents after…”
Get full text

Acral cutaneous lesions in the time of COVID‐19 by Recalcati, S., Barbagallo, T., Frasin, L.A., Prestinari, F., Cogliardi, A., Provero, M.C., Dainese, E., Vanzati, A., Fantini, F.

Get full text

European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo by Pereira, M.P., Steinke, S., Zeidler, C., Forner, C., Riepe, C., Augustin, M., Bobko, S., Dalgard, F., Elberling, J., Garcovich, S., Gieler, U., Gonçalo, M., Halvorsen, J. A., Leslie, T.A., Metz, M., Reich, A., Şavk, E., Schneider, G., Serra‐Baldrich, E., Ständer, H.F., Streit, M., Wallengren, J., Weller, K., Wollenberg, A., Bruland, P., Soto‐Rey, I., Storck, M., Dugas, M., Weisshaar, E., Szepietowski, J.C., Legat, F.J., Ständer, S.

“…Background The term prurigo has been used for many decades in dermatology without clear definition, and currently used terminology of prurigo is inconsistent…”
Get full text

European consensus statement on phenotypes of pustular psoriasis by Navarini, A.A., Burden, A.D., Capon, F., Mrowietz, U., Puig, L., Köks, S., Kingo, K., Smith, C., Barker, J.N., Bachelez, Hervé, Chiricozzi, Andrea, Costanzo, Antonio, Eyerich, Kilian, French, Lars E., Ghoreschi, Kamran, Gilliet, Michel, Girolomoni, Giampiero, Gniadecki, Robert, Griffiths, Christopher, Koh, Hong Yi, Lipsker, Dan, Naldi, Luigi, Prans, Ele, Prinz, Jörg, Reich, Kristian, Röcken, Martin, Skov, Lone, Sorin, George, Ståhle, Mona, Stingl, Georg, Van de Kerkhof, Peter, Warren, Richard

“…Pustular psoriasis (PP) is a group of inflammatory skin conditions characterized by infiltration of neutrophil granulocytes in the epidermis to such an extent…”
Get full text

Cutaneous manifestations in COVID‐19: a new contribution by Estébanez, A., Pérez‐Santiago, L., Silva, E., Guillen‐Climent, S., García‐ Vázquez, A., Ramón, M.D.

Get full text

ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients by Wollenberg, A., Oranje, A., Deleuran, M., Simon, D., Szalai, Z., Kunz, B., Svensson, A., Barbarot, S., von Kobyletzki, L., Taieb, A., de Bruin-Weller, M., Werfel, T., Trzeciak, M., Vestergard, C., Ring, J., Darsow, U.

“…Atopic dermatitis (AD) is a clinically defined, highly pruritic, chronic inflammatory skin disease of children and adults. The diagnosis is made using…”
Get full text

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain‐like lesions: lights and shadows on the relationship with COVID‐19 infection by El Hachem, M., Diociaiuti, A., Concato, C., Carsetti, R., Carnevale, C., Ciofi Degli Atti, M., Giovannelli, L., Latella, E., Porzio, O., Rossi, S., Stracuzzi, A., Zaffina, S., Onetti Muda, A., Zambruno, G., Alaggio, R.

“…Background Acral chilblain‐like lesions are being increasingly reported during COVID‐19 pandemic. However, only few patients proved positivity for SARS‐CoV‐2…”
Get full text

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC by Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.

Get full text

A distinctive skin rash associated with coronavirus disease 2019? by Mahé, A., Birckel, E., Krieger, S., Merklen, C., Bottlaender, L.

Get full text

Secukinumab demonstrates high sustained efficacy and a favourable safety profile in patients with moderate‐to‐severe psoriasis through 5 years of treatment (SCULPTURE Extension Study) by Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Lacombe, A., Xia, S., Mazur, R., Patekar, M., Charef, P., Milutinovic, M., Leonardi, C., Mrowietz, U.

“…Background Secukinumab, a fully human monoclonal antibody that selectively neutralizes IL‐17A, has been shown to have significant efficacy and a favourable…”
Get full text

Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection by Damme, C., Berlingin, E., Saussez, S., Accaputo, O.

Get full text

Cutaneous manifestations in COVID‐19: the experiences of Barcelona and Rome by Tammaro, A., Adebanjo, G.A.R., Parisella, F.R., Pezzuto, A., Rello, J.

Get full text

Sonidegib and vismodegib in the treatment of patients with locally advanced basal cell carcinoma: a joint expert opinion by Dummer, R., Ascierto, P.A., Basset‐Seguin, N., Dréno, B., Garbe, C., Gutzmer, R., Hauschild, A., Krattinger, R., Lear, J.T., Malvehy, J., Schadendorf, D., Grob, J.J.

“…Sonidegib and vismodegib are hedgehog pathway inhibitors (HhIs) approved for the treatment of advanced basal cell carcinoma (BCC). Until recently, vismodegib…”
Get full text

What is new in the pathophysiology of acne, an overview by Dréno, B.

“…Acne is a chronic inflammatory disease of the pilosebaceous unit. Its pathophysiology includes hyperseborrhoea, abnormal follicular keratinization and…”
Get full text